Written by Klarity Editorial Team
Published: Jul 18, 2026

Last updated: July 18, 2026
If you have Cigna health insurance in New Hampshire and are managing anxiety, understanding your coverage may help you access care more affordably. This guide explains how Cigna may cover anxiety treatment in New Hampshire, including what medications the Express Scripts (ESI) formulary may include, how New Hampshire’s Electronic Prescribing of Controlled Substances (EPCS) law applies to anxiety medications, and how the state’s mental health parity statute protects your access to treatment.
Key Facts. Cigna Anxiety Coverage in New Hampshire (2026)
- Insurer: Cigna Health and Life Insurance Company
- PBM: Express Scripts (ESI)
- State parity law: RSA 417-E:1 (mental health parity, fully insured commercial plans)
- NH EPCS law: RSA 318-B:21-a. Covers Schedule II through V controlled substances
- Benzodiazepines (Schedule IV): EPCS required under RSA 318-B:21-a
- Pregabalin (Schedule V): EPCS required under RSA 318-B:21-a
- SSRIs / SNRIs / buspirone / hydroxyzine: Not scheduled. NH EPCS entirely inapplicable
- Cigna PA Policy IP0477: Applies to stimulants only. Does NOT apply to anxiety medications
- Telehealth parity: RSA 415-J:2
- Member services: 1-800-244-6224 | ESI: 1-800-835-3784 | NH Insurance Department: 1-800-852-3416
Cigna health insurance plans in New Hampshire may cover a range of anxiety treatments, including therapy, psychiatric evaluation, and prescription medications. Coverage details vary by plan type (HMO, PPO, EPO), employer group, and whether the plan is fully insured (subject to NH state law) or self-funded under ERISA (governed by federal MHPAEA). Patients should always verify their specific benefits by calling Cigna member services at 1-800-244-6224 or logging into myCigna.com before scheduling a visit.
Cigna partners with Express Scripts (ESI) as its pharmacy benefit manager (PBM). The ESI formulary determines which anxiety medications may be covered, at what cost tier, and whether prior authorization (PA) is required. Most first-line anxiety medications. Including generic SSRIs and SNRIs. Typically appear on Tier 1 or Tier 2 of the ESI formulary and often do not require PA.
The following table reflects typical ESI commercial formulary tiers. Actual tier placement, PA requirements, and quantity limits vary by specific Cigna plan and may differ from what is shown. Always verify with ESI (1-800-835-3784) or myCigna.com for your plan’s current formulary.
| Medication | Class | ESI Tier (Est.) | PA Required? | Schedule | NH EPCS (RSA 318-B:21-a) |
|---|---|---|---|---|---|
| Sertraline (Zoloft generic) | SSRI | Tier 1 | Rarely | Not scheduled | EPCS inapplicable |
| Escitalopram (Lexapro generic) | SSRI | Tier 1 | Rarely | Not scheduled | EPCS inapplicable |
| Paroxetine (Paxil generic) | SSRI | Tier 1 | Rarely | Not scheduled | EPCS inapplicable |
| Fluoxetine (Prozac generic) | SSRI | Tier 1 | Rarely | Not scheduled | EPCS inapplicable |
| Venlafaxine (Effexor generic) | SNRI | Tier 1. 2 | Rarely | Not scheduled | EPCS inapplicable |
| Duloxetine (Cymbalta generic) | SNRI | Tier 1. 2 | Rarely | Not scheduled | EPCS inapplicable |
| Buspirone (BuSpar generic) | Anxiolytic | Tier 1 | No | Not scheduled | EPCS inapplicable |
| Hydroxyzine (Vistaril/Atarax) | Antihistamine/anxiolytic | Tier 1 | No | Not scheduled | EPCS inapplicable |
| Propranolol (Inderal generic) | Beta-blocker | Tier 1. 2 | Rarely | Not scheduled | EPCS inapplicable |
| Gabapentin (Neurontin generic) | Anticonvulsant/anxiolytic | Tier 1. 2 | Rarely | Not scheduled | EPCS inapplicable |
| Lorazepam (Ativan generic) | Benzodiazepine | Tier 2 | Quantity limits | Schedule IV | EPCS REQUIRED in NH |
| Clonazepam (Klonopin generic) | Benzodiazepine | Tier 2 | Quantity limits | Schedule IV | EPCS REQUIRED in NH |
| Alprazolam (Xanax generic) | Benzodiazepine | Tier 2 | Quantity limits | Schedule IV | EPCS REQUIRED in NH |
| Diazepam (Valium generic) | Benzodiazepine | Tier 2 | Quantity limits | Schedule IV | EPCS REQUIRED in NH |
| Pregabalin (Lyrica generic) | Anticonvulsant/anxiolytic | Tier 2. 3 | Sometimes | Schedule V | EPCS REQUIRED in NH |
Disclaimer: Tier placements and PA requirements are estimates based on publicly available ESI formulary data. Your specific Cigna plan may differ. Verify at myCigna.com or call ESI at 1-800-835-3784. Coverage varies by plan and may not cover all medications listed. Always verify your benefits before booking an appointment.
New Hampshire’s Electronic Prescribing of Controlled Substances law, codified at RSA 318-B:21-a, requires that prescriptions for controlled substances be transmitted electronically rather than on paper. This law is notably broader than many other state EPCS statutes and the federal baseline standard.
For anxiety treatment specifically, RSA 318-B:21-a has the following implications:
Benzodiazepines. Including lorazepam (Ativan), clonazepam (Klonopin), alprazolam (Xanax), and diazepam (Valium). Are classified as Schedule IV controlled substances under federal and New Hampshire law. Under RSA 318-B:21-a, all Schedule IV substances are subject to mandatory electronic prescribing in New Hampshire. This means that when a Cigna-covered provider prescribes a benzodiazepine, they must transmit the prescription electronically to the pharmacy. Paper prescriptions for benzodiazepines are generally not permitted in New Hampshire except in specific limited circumstances (e.g., prescriber system outage).
Pregabalin (Lyrica, generic available) is classified as a Schedule V controlled substance and is sometimes prescribed off-label for generalized anxiety disorder. Under RSA 318-B:21-a, which covers Schedule II through V, pregabalin prescriptions in New Hampshire must also be transmitted electronically. This is a meaningful distinction from Hawaii (HRS § 329-38.5, Schedule II only) and the federal baseline standard (42 CFR § 456.44, Schedule II only), where pregabalin as a Schedule V substance would not be subject to EPCS requirements.
The vast majority of first-line anxiety medications. Including all SSRIs (sertraline, escitalopram, paroxetine, fluoxetine), SNRIs (venlafaxine, duloxetine), buspirone, hydroxyzine, propranolol, and gabapentin. Are not classified as controlled substances under federal or New Hampshire law. As a result, RSA 318-B:21-a’s EPCS mandate is entirely inapplicable to these medications. Providers may transmit prescriptions for these medications electronically or on paper; there is no state-law electronic prescribing requirement for non-scheduled anxiolytics.
| State / Law | Scope | Benzos (Schedule IV) | Pregabalin (Schedule V) |
|---|---|---|---|
| New Hampshire (RSA 318-B:21-a) | Schedule II. V (broad) | EPCS REQUIRED | EPCS REQUIRED |
| Hawaii (HRS § 329-38.5) | Schedule II only | Not required (Schedule IV) | Not required (Schedule V) |
| Federal baseline (42 CFR § 456.44) | Schedule II only | Not required (Schedule IV) | Not required (Schedule V) |
New Hampshire’s RSA 318-B:21-a is one of the broader EPCS statutes in the country, extending the electronic prescribing mandate through Schedule V. Patients and providers new to the New Hampshire market should be aware that benzodiazepine and pregabalin prescriptions must be transmitted electronically even though these medications are not subject to EPCS requirements in most other states or under federal law.
Cigna implemented Prior Authorization Policy IP0477 effective May 15, 2026, which requires prior authorization for all ADHD stimulant medications regardless of whether they are generic or brand-name. This policy was widely discussed in the context of ADHD treatment.
IP0477 does not apply to anxiety medications. The policy is specifically scoped to stimulant medications used for ADHD and related attention conditions. Anxiolytics. Including SSRIs, SNRIs, benzodiazepines, buspirone, hydroxyzine, and pregabalin. Are not affected by IP0477. Prior authorization requirements for anxiety medications on the ESI formulary are governed by standard Cigna/ESI formulary management policies and step therapy requirements, not by IP0477.
While IP0477 does not apply to anxiety medications, some anxiety treatments may still require prior authorization under standard ESI formulary policies:
New Hampshire’s mental health parity statute, RSA 417-E:1, requires that fully insured commercial insurance plans. Including Cigna’s fully insured plans sold in New Hampshire. Provide coverage for mental health and substance use disorder treatment on terms no more restrictive than coverage for medical and surgical conditions.
Under RSA 417-E:1, Cigna may not apply quantitative limits (such as lower day or visit limits) or non-quantitative treatment limitations (NQTLs). Such as PA requirements or step therapy. To anxiety treatment that are more restrictive than those applied to comparable medical or surgical benefits under the same plan. This means:
If your Cigna coverage is through an employer that self-funds its health plan, the plan is governed by ERISA (the Employee Retirement Income Security Act) rather than New Hampshire state law. ERISA self-funded plans are subject to the federal Mental Health Parity and Addiction Equity Act (MHPAEA) rather than RSA 417-E:1. The parity protections are similar in substance; however, enforcement through the New Hampshire Insurance Department does not apply to ERISA plans. Contact your HR department or plan administrator to determine whether your plan is fully insured or self-funded.
New Hampshire’s telehealth parity statute, RSA 415-J:2, requires that fully insured commercial plans cover telehealth services on terms comparable to in-person services. For anxiety treatment, this means Cigna may not refuse coverage for a telehealth psychiatry or therapy visit solely because the service is delivered via video or telephone rather than in person. Providers who see New Hampshire Cigna patients through telehealth platforms are generally eligible for reimbursement at parity with in-person rates for covered services.
Cigna plans in New Hampshire may cover evaluation and treatment for a range of anxiety-related conditions, including:
Coverage for a specific diagnosis depends on your individual plan’s terms, network requirements, and medical necessity criteria. Verify your benefits for the specific diagnostic code before scheduling a visit.
Klarity Health works with a network of 2,000+ licensed psychiatric and medical providers across the country, including providers licensed in New Hampshire. Klarity’s telehealth platform connects patients with providers who specialize in anxiety treatment, including medication management for SSRIs, SNRIs, buspirone, and other first-line anxiolytics.
Klarity’s providers operate using fully compliant electronic prescribing systems. For New Hampshire patients, this means prescriptions for any controlled substances. Including benzodiazepines (Schedule IV) and pregabalin (Schedule V). Are transmitted electronically in compliance with RSA 318-B:21-a when clinically appropriate and legally permissible via telehealth.
Coverage verification is the patient’s responsibility. Klarity recommends calling Cigna (1-800-244-6224) and ESI (1-800-835-3784) before booking to confirm whether your specific plan may cover telehealth anxiety treatment and the medications your provider may recommend.
Cigna plans in New Hampshire may cover anxiety medications through the Express Scripts (ESI) formulary. First-line medications such as generic SSRIs and SNRIs typically appear at Tier 1. 2 and often do not require prior authorization. Coverage varies by plan type and employer group. Verify your specific benefits by calling Cigna at 1-800-244-6224 or checking myCigna.com before booking an appointment. Coverage varies by plan and should always be verified before booking.
Yes. Under RSA 318-B:21-a, benzodiazepines. Which are classified as Schedule IV controlled substances. Require electronic prescribing in New Hampshire. This applies to lorazepam, clonazepam, alprazolam, diazepam, and other benzodiazepines regardless of who the prescriber is or the patient’s insurance carrier. Paper prescriptions for benzodiazepines are generally not permitted in New Hampshire except in specific limited circumstances.
No. Cigna’s Prior Authorization Policy IP0477, which took effect May 15, 2026, applies specifically to stimulant medications used for ADHD. It does not apply to anxiety medications including SSRIs, SNRIs, benzodiazepines, buspirone, hydroxyzine, or pregabalin. Standard ESI formulary PA and step therapy requirements continue to apply to anxiety medications as they did before IP0477.
Pregabalin (Lyrica, generic available) may appear on the ESI formulary at Tier 2. 3 and is sometimes prescribed off-label for generalized anxiety disorder. As a Schedule V controlled substance, pregabalin prescriptions require electronic prescribing in New Hampshire under RSA 318-B:21-a. Coverage and PA requirements vary by plan. Verify with ESI at 1-800-835-3784 whether your specific plan includes pregabalin for anxiety and whether PA is required.
If your Cigna plan is fully insured, RSA 417-E:1 requires that mental health benefits. Including anxiety treatment. Be provided on terms no more restrictive than comparable medical or surgical benefits. If your plan is self-funded under ERISA, the federal MHPAEA provides similar protections. Contact Cigna at 1-800-244-6224 or the NH Insurance Department at 1-800-852-3416 if you believe parity requirements are not being met.
Cigna’s fully insured plans in New Hampshire may cover telehealth anxiety treatment under RSA 415-J:2, which requires parity between telehealth and in-person services. Confirm with Cigna (1-800-244-6224) whether your specific plan covers telehealth behavioral health visits and whether your provider’s platform is compatible with Cigna’s network and billing processes.
Disclaimer: This content is for general informational purposes only and does not constitute legal, medical, or insurance advice. Insurance coverage varies by plan, employer group, and individual circumstances. Coverage described here reflects typical or estimated plan features based on publicly available information and may not reflect your specific plan. Always verify your benefits directly with Cigna and ESI before scheduling an appointment or filling a prescription. Klarity Health makes no guarantees about coverage or reimbursement for any specific service or medication. Coverage varies by plan and should always be verified before booking.
Find the right provider for your needs — select your state to find expert care near you.